Interestingly, bevacizumab, an anti-VEGF antibody that decreases VEGF signaling in a manner similar to sFlt-1, causes hypertension and proteinuria in nonpregnant individuals [45–47]. This evidence concerns the gene VEGFA and hypertensive disorder.